Roche Czech Republic made a net profit of CZK CZK 51.0 mil under revenues of CZK 5,445 mil in 2015, down 46.3% and 24.8%, respectively, when compared to the last year.
This translates into a net margin of 0.936%. Historically, the firm’s net margin reached an all time high of 3.03% in 2008 and an all time low of 0.126% in 2003. The average net margin in the last five years amounted to 1.53%.
On the operating level, EBITDA margin reached 1.50% and EBIT amounted to 3.84% of sales in 2015.
As far as Roche Czech Republic's peers are concerned, Bayer Czech Republic posted net and EBITDA margin of 2.89% and 3.93%, respectively in 2015 and Amgen Czech Republic generated margins of 5.93% and 7.66%.